Companies / Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc.
Nasdaq: DYNCIK 1818794WALTHAM, MA
Financials
Ownership
186.7M shares outstanding · as of Jul 24, 2026
Ownership
| Insiders | 2.95% | 5,500,318 |
| 10%+ / strategic | 14.23% | 26,578,437 |
| Institutions | 85.89% | 160,392,383 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Kersten DirkDirector | 2.49% | 4,644,386 |
Cox JohnCEOCEO & President · Director | 0.20% | 374,145 |
Kerr DouglasChief Medical Officer | 0.09% | 171,606 |
Friedl-Naderer JohannaChief Commercial Officer | 0.08% | 154,581 |
Lucera ErickChief Financial Officer | 0.07% | 131,100 |
Posner Brian SDirector | 0.01% | 24,500 |
Greene Barry EDirector | — | — |
Hurwitz EdwardDirector | — | — |
Institutional holders 241
View all →| Holder | Value | % of shares |
|---|---|---|
| $275.50M | 6.64% | |
| $247.43M | 7.31% | |
| $219.38M | 6.01% | |
| $178.59M | 4.89% | |
| $165.65M | 3.99% | |
| $128.51M | 3.52% | |
| $106.85M | 2.93% | |
| $93.93M | 2.57% | |
| $90.27M | 2.47% | |
| $84.65M | 2.50% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Kersten Dirk Director | Sell | Common Stock | $5.58M | -282K -5.57% | 4,774,058 2.56% of shares | medium |
| Mar 10, 2026 | Kersten Dirk Director | Sell | Common Stock | $4.25M | -220K -4.17% | 5,055,916 2.71% of shares | medium |
| Mar 9, 2026 | Kersten Dirk Director | Sell | Common Stock | $3.15M | -178K -3.25% | 5,285,156 2.83% of shares | medium |
| Mar 11, 2026 | Kersten Dirk Director | Sell | Common Stock | $2.53M | -130K -2.72% | 4,644,386 2.49% of shares | medium |
| Mar 10, 2026 | Kersten Dirk Director | Sell | Common Stock | $172.7K | -9K -0.18% | 5,275,674 2.83% of shares | medium |
| Mar 6, 2026 | Posner Brian S Director | Buy | Common Stock | $45.2K | +3K +35.29% | 11,500 <0.01% of shares | low |
| Jun 3, 2026 | Posner Brian S Director | Buy | Common Stock | $43.7K | +3K +12.50% | 22,500 0.01% of shares | low |
| May 20, 2026 | Posner Brian S Director | Buy | Common Stock | $42.8K | +3K +16.13% | 18,000 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| T. Rowe Price Investment Management, Inc. | Passive13G/A | — |
| T. Rowe Price Investment Management, Inc. | Passive13G | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| DYN | — | 26818M108 |